ENSC reverse stock split range 1-for-10 to 1-for-30 (board to decide)
Ensysce Biosciences, Inc. · UNKNOWN
- Status
- Proposed in a proxy statement (not yet confirmed)
- Ratio
- range 1-for-10 to 1-for-30 (board to decide)
- Fractional shares
- UNKNOWN fractional treatment unknown
- Effective date
- Dec 6, 2024
- Split-adjusted trading
- unknown
- Days until
- n/a
- New CUSIP
- unknown
- Other tickers
- none
- SEC CIK
- 1716947
- Filing
- PRE 14A filed Oct 30, 2026
Broker payout history
No confirmed broker reports yet.
Source filings
- 8-K filed Aug 6, 2026: https://www.sec.gov/Archives/edgar/data/1716947/000149315226036268/0001493152-26-036268-index.htm
- PRE 14A filed Oct 30, 2026: https://www.sec.gov/Archives/edgar/data/1716947/000149315226049475/0001493152-26-049475-index.htm
Extracted automatically from the filing text. Unknown means we could not confirm it from the filing. Read the filing before acting. Information only, not financial advice.
Brokers (placeholder)
Broker partner links will appear here. Advertising disclosure: we may earn a commission if you open an account through a link on this site.